HHS concluded there was no evidence to deny such funds to Fort Defiance Indian Hospital, which serves 47,000 Native Americans, most of whom are Navajo. The dispute had already sparked previous litigation.
The dispute over Fort Defiance Indian Hospital’s contract support costs dates to October of last year, when the IHS cut its allocation for fiscal 2022 from $18.5 million to just $1.5 million, a move the agency said was needed to correct past spending inaccuracies.
Fort Defiance, meanwhile, asked the IHS earlier this year to refund $19.6 million in indirect contract support costs for the current fiscal year, according to agency records.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
